United States Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

February 2017 | 118 pages | ID: U6E590FE747EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Viral Vectors and Plasmid DNA Manufacturing

Revenue, means the sales value of Viral Vectors and Plasmid DNA Manufacturing

This report studies sales (consumption) of Viral Vectors and Plasmid DNA Manufacturing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Aldevron
• Eurogentec
• Richter-Helm
• BioReliance (A Part of SAFC Commercial)
• Biovian
• Brammer Bio
• Cell and Gene Therapy Catapult
• Cobra Biologics
• FinVector
• FUJIFILM Diosynth Biotechnologies
• Lonza
• MassBiologics
• MolMed
• Oxford BioMedica
• Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
• Spark Therapeutics
• uniQure
• ViGene Biosciences
• Wuxi AppTec

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Plasmid DNA
• Viral Vectors
• Non-Viral Vectors

Split by applications, this report focuses on sales, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in each application, can be divided into

• Cancers
• Inherited Disorders
• Viral Infections
• Others

Contents

United States Viral Vectors and Plasmid DNA Manufacturing Market Report 2017

1 VIRAL VECTORS AND PLASMID DNA MANUFACTURING OVERVIEW

1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing
  1.2.1 Plasmid DNA
  1.2.2 Viral Vectors
  1.2.3 Non-Viral Vectors
1.3 Application of Viral Vectors and Plasmid DNA Manufacturing
  1.3.1 Cancers
  1.3.2 Inherited Disorders
  1.3.3 Viral Infections
  1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
  1.4.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
  1.4.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)

2 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING COMPETITION BY MANUFACTURERS

2.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Viral Vectors and Plasmid DNA Manufacturing Average Price by Manufactures (2015 and 2016)
2.4 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
  2.4.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
  2.4.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by States (2012-2017)
3.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by States (2012-2017)
3.3 United States Viral Vectors and Plasmid DNA Manufacturing Price by States (2012-2017)

4 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)
4.2 United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
4.3 United States Viral Vectors and Plasmid DNA Manufacturing Price by Type (2012-2017)
4.4 United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application (2012-2017)
5.2 United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING MANUFACTURERS PROFILES/ANALYSIS

6.1 Aldevron
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.1.2.1 Plasmid DNA
    6.1.2.2 Viral Vectors
  6.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eurogentec
  6.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.2.2.1 Plasmid DNA
    6.2.2.2 Viral Vectors
  6.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Richter-Helm
  6.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.3.2.1 Plasmid DNA
    6.3.2.2 Viral Vectors
  6.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BioReliance (A Part of SAFC Commercial)
  6.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.4.2.1 Plasmid DNA
    6.4.2.2 Viral Vectors
  6.4.3 BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biovian
  6.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.5.2.1 Plasmid DNA
    6.5.2.2 Viral Vectors
  6.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Brammer Bio
  6.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.6.2.1 Plasmid DNA
    6.6.2.2 Viral Vectors
  6.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cell and Gene Therapy Catapult
  6.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.7.2.1 Plasmid DNA
    6.7.2.2 Viral Vectors
  6.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cobra Biologics
  6.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.8.2.1 Plasmid DNA
    6.8.2.2 Viral Vectors
  6.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 FinVector
  6.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.9.2.1 Plasmid DNA
    6.9.2.2 Viral Vectors
  6.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 FUJIFILM Diosynth Biotechnologies
  6.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
    6.10.2.1 Plasmid DNA
    6.10.2.2 Viral Vectors
  6.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lonza
6.12 MassBiologics
6.13 MolMed
6.14 Oxford BioMedica
6.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
6.16 Spark Therapeutics
6.17 uniQure
6.18 ViGene Biosciences
6.19 Wuxi AppTec

7 VIRAL VECTORS AND PLASMID DNA MANUFACTURING MANUFACTURING COST ANALYSIS

7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET FORECAST (2017-2022)

11.1 United States Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue Forecast (2017-2022)
11.2 United States Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)
11.3 United States Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)
11.4 Viral Vectors and Plasmid DNA Manufacturing Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral Vectors and Plasmid DNA Manufacturing
Table Classification of Viral Vectors and Plasmid DNA Manufacturing
Figure United States Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type in 2015
Figure Plasmid DNA Picture
Figure Viral Vectors Picture
Figure Non-Viral Vectors Picture
Table Application of Viral Vectors and Plasmid DNA Manufacturing
Figure United States Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application in 2015
Figure Cancers Examples
Figure Inherited Disorders Examples
Figure Viral Infections Examples
Figure Others Examples
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales of Key Manufacturers (2015 and 2016)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers
Figure 2016 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue by Manufacturers (2015 and 2016)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Table 2016 United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Table United States Market Viral Vectors and Plasmid DNA Manufacturing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Viral Vectors and Plasmid DNA Manufacturing Average Price of Key Manufacturers in 2015
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers
Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales by States (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by States (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by States in 2015
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by States (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by States (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by States (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Price by States (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type in 2015
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Price by Type (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2012-2017)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Application in 2015
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2012-2017)
Table Aldevron Basic Information List
Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Eurogentec Basic Information List
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Richter-Helm Basic Information List
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table BioReliance (A Part of SAFC Commercial) Basic Information List
Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Biovian Basic Information List
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Brammer Bio Basic Information List
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Cell and Gene Therapy Catapult Basic Information List
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Cobra Biologics Basic Information List
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table FinVector Basic Information List
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Basic Information List
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Lonza Basic Information List
Table MassBiologics Basic Information List
Table MolMed Basic Information List
Table Oxford BioMedica Basic Information List
Table Sanofi (CEPiA, Sanofi Pasteur, Genzyme) Basic Information List
Table Spark Therapeutics Basic Information List
Table uniQure Basic Information List
Table ViGene Biosciences Basic Information List
Table Wuxi AppTec Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing
Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
Table Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015
Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing
Table Distributors/Traders List
Figure United States Viral Vectors and Plasmid DNA Manufacturing Production and Growth Rate Forecast (2017-2022)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Production Forecast by Type (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Consumption Forecast by Application (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by States (2017-2022)
Table United States Viral Vectors and Plasmid DNA Manufacturing Sales Share Forecast by States (2017-2022)